Yaz and Yasmin are birth control pills that combine two hormones. You take one pill by mouth every day. They stop the ovaries from releasing an egg, and some versions also help with acne and severe mood symptoms before a period.
Every report comes from a Lived member, sent anonymously.
Have you tried Yaz / Yasmin (Drospirenone / Ethinyl Estradiol) for PMDD (Premenstrual Dysphoric Disorder)?
Yaz and Yasmin are brand-name birth control pills that combine two hormones: drospirenone, a progestin, and ethinyl estradiol, a form of estrogen. Both are taken daily to prevent pregnancy. Generic versions are widely available, including Loryna (equivalent to Yaz) and Ocella and Syeda (equivalent to Yasmin). The two brands are not interchangeable. Yaz has a slightly lower estrogen dose and 24 hormone pills per pack, and it carries two extra approvals for people who also want birth control: treating the symptoms of premenstrual dysphoric disorder (PMDD), a severe form of premenstrual mood symptoms that disrupts work, school or relationships, and treating moderate acne in people at least 14 years old who have started having periods. Yasmin is approved only for preventing pregnancy. Yaz has not been studied for ordinary premenstrual syndrome (PMS), and its PMDD benefit was tested over three cycles.
Like other combined pills, drospirenone and ethinyl estradiol work mainly by stopping ovulation, the monthly release of an egg from an ovary. With a steady daily dose of estrogen and progestin, the ovaries do not release an egg, so there is nothing to fertilize. Drospirenone is what sets these pills apart from other combined pills. It is chemically related to spironolactone, a medicine that blocks the hormone aldosterone and some effects of androgens (hormones such as testosterone). The anti-androgen effect is relevant to acne, which is driven partly by androgens stimulating the skin's oil glands. The aldosterone-blocking effect means drospirenone can raise the level of potassium in the blood in some people, which is why kidney health and certain other medicines matter when choosing this pill.
Take one tablet by mouth at the same time every day, in the order shown on the pack, with or without food. A Yaz pack has 24 light pink hormone pills followed by 4 white inactive pills; a Yasmin pack has 21 yellow hormone pills followed by 7 white ones. A period-like bleed usually comes during the inactive days. The next pack starts the day after the last inactive pill, whether or not bleeding has stopped. Generic packs follow the schedule of the brand they match. Starting on the first day of a period protects from the first pill. Starting later, such as on the first Sunday after a period begins, requires a backup method like condoms for the first 7 days. If one hormone pill is missed, take it as soon as you remember and take the next one at the usual time, even if that means two in one day; no backup is needed. If two or more hormone pills in a row are missed, the steps depend on the week of the pack and how it was started, and a backup method is needed for 7 days, so follow the pack's instructions or ask a pharmacist. Vomiting within 3 to 4 hours of a pill, or severe diarrhea, can count as a missed pill. Missing inactive pills does not reduce protection.
In clinical trials, the most common side effects were headache, irregular bleeding or spotting, nausea, breast tenderness and mood changes. Spotting between periods is most common in the first three months and often settles. Some people have little or no bleeding during the inactive days even when they are not pregnant. Among people taking Yaz in the PMDD trials, side effects were reported more often than in the contraception trial: irregular bleeding by about one in four users, nausea by about one in six and headache by about one in eight. Bleeding that persists, or starts after cycles had been regular, is worth having checked. Blood clots are the most important serious risk. Get emergency care right away for leg pain, sudden chest pain, shortness of breath, a sudden severe headache, sudden changes in vision, weakness or numbness in an arm or leg, or trouble speaking. These can signal a clot in the leg or lung, a heart attack or a stroke. Contact the prescriber promptly about yellowing of the skin or eyes, migraines that become more frequent or severe, new headaches that keep coming back or are severe, or depression that returns or worsens.
The boxed warning concerns smoking. Cigarette smoking raises the risk of heart attack and stroke with combined pills, more so with age and with heavier smoking, and people over 35 who smoke should not use this medicine. Pills containing drospirenone may carry a higher risk of blood clots in the veins than pills containing levonorgestrel, another common progestin; studies range from no difference to about three times the risk. The absolute risk is still low. The label estimates 3 to 9 clots per 10,000 women per year on combined pills, compared with 1 to 5 in women who are not pregnant and not using them, and the risk during pregnancy and after delivery is higher still. The risk is greatest in the first year and when restarting after a break of four weeks or more. Prescribers weigh this against personal risk factors such as obesity, smoking and a family history of clots. When possible, the pill is stopped at least 4 weeks before major surgery. It should not be used by people with current or past blood clots, an inherited or acquired clotting disorder, stroke or heart disease, uncontrolled high blood pressure, diabetes with blood vessel, kidney, eye or nerve damage, headaches with neurological symptoms such as aura, any type of migraine after age 35, breast cancer, liver disease or liver tumors, kidney disease, adrenal insufficiency (underactive adrenal glands) or unexplained vaginal bleeding. Because drospirenone can raise potassium, anyone who takes a potassium-raising medicine every day should have a potassium blood test during the first month. These include ACE inhibitors and ARBs (common blood pressure medicines), potassium-sparing diuretics (water pills), potassium supplements, heparin (an injected blood thinner) and daily NSAID pain relievers such as ibuprofen. Some medicines make the pill less reliable, including the seizure medicines carbamazepine, phenytoin, oxcarbazepine and topiramate, the antibiotic rifampin and the herbal supplement St. John's wort. Use a backup method while taking them and for 28 days after stopping. In the other direction, the pill can lower levels of lamotrigine, a seizure and mood medicine, so its dose may need adjusting, and people taking thyroid hormone may need a higher dose. The pill does not protect against HIV or other sexually transmitted infections. It can reduce breast milk supply, so another method is usually preferred while breastfeeding.
Taken consistently, it is highly effective: in the main Yaz trial, about 1.4 pregnancies occurred per 100 women over a year of use, and the chance rises when pills are missed or taken late. Spotting and nausea are most likely in the first few months. If irregular bleeding continues, it may settle with time or with a switch to a different pill. Acne improvement is judged over about six months of use, not weeks. In the PMDD trials, people rated the mood and physical symptoms that define PMDD every day; those symptoms also improved considerably with a placebo pill, so Yaz added a real but moderate benefit on top of that. A missed period after missed pills, or two missed periods in a row even with perfect use, calls for a pregnancy test. If pregnancy is confirmed, stop the pill; studies have not found more birth defects after accidental use in early pregnancy. The pill can raise blood pressure in some people, more often with age and longer use, so blood pressure is checked periodically while taking it. The extra clot risk from the pill gradually disappears after it is stopped.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience taking Yaz / Yasmin (Drospirenone / Ethinyl Estradiol), what you've noticed, or ask the community a question.